59
Views
25
CrossRef citations to date
0
Altmetric
Review

Current advances of long non-coding RNA highly upregulated in liver cancer in human tumors

, , , , , , , & show all
Pages 4711-4717 | Published online: 25 Sep 2017

References

  • JiangYMaloufGGZhangJLong non-coding RNA profiling links subgroup classification of endometrioid endometrial carcinomas with trithorax and polycomb complex aberrationsOncotarget2015637398653987626431491
  • LiXWuZFuXHanWlncRNAs: insights into their function and mechanics in underlying disordersMutat Res Rev Mutat Res201476212125485593
  • HeYMengXMHuangCLong noncoding RNAs: novel insights into hepatocellular carcinomaCancer Lett20143441202724183851
  • WangKCChangHYMolecular mechanisms of long noncoding RNAsMol Cell201143690491421925379
  • TsaiMCManorOWanYLong noncoding RNA as modular scaffold of histone modification complexesScience2010329599268969320616235
  • WangFYuanJHWangSBOncofetal long noncoding RNA PVT1 promotes proliferation and stem cell-like property of hepatocellular carcinoma cells by stabilizing NOP2Hepatology20146041278129025043274
  • YangFZhangLHuoXSLong noncoding RNA high expression in hepatocellular carcinoma facilitates tumor growth through enhancer of zeste homolog 2 in humansHepatology20115451679168921769904
  • YuanSXYangFYangYLong noncoding RNA associated with microvascular invasion in hepatocellular carcinoma promotes angiogenesis and serves as a predictor for hepatocellular carcinoma patients’ poor recurrence-free survival after hepatectomyHepatology20125662231224122706893
  • LiSPXuHXYuYLncRNA HULC enhances epithelial-mesenchymal transition to promote tumorigenesis and metastasis of hepatocellular carcinoma via the miR-200a-3p/ZEB1 signaling pathwayOncotarget2016727424314244627285757
  • JinCShiWWangFLong non-coding RNA HULC as a novel serum biomarker for diagnosis and prognosis prediction of gastric cancerOncotarget2016732517635177227322075
  • YangXJHuangCQPengCWHouJXLiuJYLong noncoding RNA HULC promotes colorectal carcinoma progression through epigenetically repressing NKD2 expressionGene2016592117217827496341
  • UzanVRLengertABoldriniEHigh expression of HULC is associated with poor prognosis in osteosarcoma patientsPLoS One2016116e156774
  • PengWWuJFengJLong noncoding RNA HULC predicts poor clinical outcome and represents pro-oncogenic activity in diffuse large B-cell lymphomaBiomed Pharmacother20167918819327044827
  • SanulliSJustinNTeissandierAJarid2 methylation via the PRC2 complex regulates H3K27me3 deposition during cell differentiationMol Cell201557576978325620564
  • LiuCLiSDaiXPRC2 regulates RNA polymerase III transcribed non-translated RNA gene transcription through EZH2 and SUZ12 interaction with TFIIIC complexNucleic Acids Res201543136270628426038315
  • XuBKonzeKDJinJWangGGTargeting EZH2 and PRC2 dependence as novel anticancer therapyExp Hematol201543869871226027790
  • GandhySUImaniradPJinUHSpecificity protein (Sp) transcription factors and metformin regulate expression of the long non-coding RNA HULCOncotarget2015628263592637226317792
  • PanzittKTschernatschMMGuellyCCharacterization of HULC, a novel gene with striking up-regulation in hepatocellular carcinoma, as noncoding RNAGastroenterology2007132133034217241883
  • WangJLiuXWuHCREB up-regulates long non-coding RNA, HULC expression through interaction with microRNA-372 in liver cancerNucleic Acids Res201038165366538320423907
  • MaYHuangDYangFLong noncoding RNA highly upregulated in liver cancer regulates the tumor necrosis factor-alpha-induced apoptosis in human vascular endothelial cellsDNA Cell Biol201635629630026981838
  • JemalASiegelRWardECancer statistics, 2008CA Cancer J Clin2008582719618287387
  • GohGBChangPETanCKChanging epidemiology of hepatocellular carcinoma in AsiaBest Pract Res Clin Gastroenterol201529691992826651253
  • ChenWZhengRBaadePDCancer statistics in China, 2015CA Cancer J Clin201666211513226808342
  • GeorgeJPatelTNoncoding RNA as therapeutic targets for hepatocellular carcinomaSemin Liver Dis2015351637425632936
  • CervelloMMcCubreyJACusimanoALampiasiNAzzolinaAMontaltoGTargeted therapy for hepatocellular carcinoma: novel agents on the horizonOncotarget20123323626022470194
  • ZhuQLiNZengXHepatocellular carcinoma in a large medical center of China over a 10-year period: evolving therapeutic option and improving survivalOncotarget2015664440445025686836
  • MaluccioMCoveyARecent progress in understanding, diagnosing, and treating hepatocellular carcinomaCA Cancer J Clin201262639439923070690
  • YangZLuYXuQTangBParkCKChenXHULC and H19 played different roles in overall and disease-free survival from hepatocellular carcinoma after curative hepatectomy: a preliminary analysis from gene expression omnibusDis Markers2015201519102926136615
  • LiJWangXTangJHULC and Linc00152 act as novel biomarkers in predicting diagnosis of hepatocellular carcinomaCell Physiol Biochem201537268769626356260
  • DuYKongGYouXElevation of highly up-regulated in liver cancer (HULC) by hepatitis B virus X protein promotes hepatoma cell proliferation via down-regulating p18J Biol Chem201228731263022631122685290
  • WanDShenSFuSmiR-203 suppresses the proliferation and metastasis of hepatocellular carcinoma by targeting oncogene ADAM9 and oncogenic long non-coding RNA HULCAnticancer Agents Med Chem201616441442326179263
  • GuiXLiHLiTPuHLuDLong noncoding RNA CUDR regulates HULC and beta-catenin to govern human liver stem cell malignant differentiationMol Ther201523121843185326347501
  • WangRSunQWangPNotch and Wnt/beta-catenin signaling pathway play important roles in activating liver cancer stem cellsOncotarget2016755754576826735577
  • LiuYPanSLiuLA genetic variant in long non-coding RNA HULC contributes to risk of HBV-related hepatocellular carcinoma in a Chinese populationPLoS One201274e3514522493738
  • CuiMXiaoZWangYLong noncoding RNA HULC modulates abnormal lipid metabolism in hepatoma cells through an miR-9-mediated RXRA signaling pathwayCancer Res201575584685725592151
  • TanPYeohKGGenetics and molecular pathogenesis of gastric adenocarcinomaGastroenterology201514951153116226073375
  • SakaMMoritaSFukagawaTKataiHPresent and future status of gastric cancer surgeryJpn J Clin Oncol201141330731321242182
  • ZhaoYGuoQChenJHuJWangSSunYRole of long non-coding RNA HULC in cell proliferation, apoptosis and tumor metastasis of gastric cancer: a clinical and in vitro investigationOncol Rep201431135836424247585
  • TorreLABrayFSiegelRLFerlayJLortet-TieulentJJemalAGlobal cancer statistics, 2012CA Cancer J Clin20156528710825651787
  • YuXLiZYuJChanMTWuWKMicroRNAs predict and modulate responses to chemotherapy in colorectal cancerCell Prolif201548550351026202377
  • YangMHYuJChenNElevated microRNA-31 expression regulates colorectal cancer progression by repressing its target gene SATB2PLoS One2013812e8535324386467
  • WangRFSongBRPengJJThe prognostic value of preoperative serum CEA and CA19-9 values in stage I–III colorectal cancerHepatogastroenterology20146113299499926158155
  • FungKYNiceEPriebeIColorectal cancer biomarkers: to be or not to be? Cautionary tales from a road well travelledWorld J Gastroenterol201420488889824574763
  • MatoukIJAbbasiIHochbergAGalunEDweikHAkkawiMHighly upregulated in liver cancer noncoding RNA is overexpressed in hepatic colorectal metastasisEur J Gastroenterol Hepatol200921668869219445043
  • MalvezziMBertuccioPLeviFLa VecchiaCNegriEEuropean cancer mortality predictions for the year 2014Ann Oncol20142581650165624759568
  • MayorSImmunotherapy improves overall survival in pancreatic cancerLancet Oncol2015162e58
  • BergmannLMauteLHeilGA prospective randomised phase-II trial with gemcitabine versus gemcitabine plus sunitinib in advanced pancreatic cancer: a study of the CESAR Central European Society for Anticancer Drug Research-EWIVEur J Cancer2015511273625459392
  • PengWGaoWFengJLong noncoding RNA HULC is a novel biomarker of poor prognosis in patients with pancreatic cancerMed Oncol2014311234625412939
  • TaucherVManggeHHaybaeckJNon-coding RNAs in pancreatic cancer: challenges and opportunities for clinical applicationCell Oncol (Dordr)201639429531827060060
  • HeHNiJHuangJMolecular mechanisms of chemoresistance in osteosarcoma (Review)Oncol Lett2014751352136224765137
  • LiuJJLiuSWangJGTelangiectatic osteosarcoma: a review of literatureOnco Targets Ther2013659360223745051
  • GuoJReddickWEGlassJODynamic contrast-enhanced magnetic resonance imaging as a prognostic factor in predicting event-free and overall survival in pediatric patients with osteosarcomaCancer2012118153776378522180392
  • HanGWangYBiWZMagnetic resonance imaging is appropriate for determining the osteotomy plane for appendicular osteosarcoma after neoadjuvant chemotherapyMed Oncol20122921347135321350876
  • SunXHYangLBGengXLWangRZhangZCIncreased expression of lncRNA HULC indicates a poor prognosis and promotes cell metastasis in osteosarcomaInt J Clin Exp Pathol2015832994300026045809
  • IqbalJNaushadHBiCGenomic signatures in B-cell lymphoma: how can these improve precision in diagnosis and inform prognosis?Blood Rev2016302738826432520
  • OmuroADeAngelisLMGlioblastoma and other malignant gliomas: a clinical reviewJAMA2013310171842185024193082
  • ZhuYZhangXQiLHULC long noncoding RNA silencing suppresses angiogenesis by regulating ESM-1 via the PI3K/Akt/mTOR signaling pathway in human gliomasOncotarget2016712144291444026894862